Inventor · disambiguated record
Hon Chung Hui
Also filed as: HUI HON · HUI HON C · HUI HON CHUNG
32 granted patents·14 pending applications·496 citations·filing 2007–2024
98Inventor score
Top patents by PatentIndex Score
46 records- 0199US11266666B2Methods for treating Filoviridae virus infectionsGILEAD SCIENCES INC·Filed 2020·Granted Mar 8, 2022·24 cites·5 claims
- 0299US9724360B2Methods for treating Filoviridae virus infectionsGILEAD SCIENCES INC·Filed 2015·Granted Aug 8, 2017·58 cites·8 claims
- 0398US10695357B2Methods for treating filoviridae virus infectionsGILEAD SCIENCES INC·Filed 2019·Granted Jun 30, 2020·28 cites·7 claims
- 0498US10251898B2Methods for treating Filoviridae virus infectionsGILEAD SCIENCES INC·Filed 2018·Granted Apr 9, 2019·39 cites·16 claims
- 0598US9949994B2Methods for treating Filoviridae virus infectionsGILEAD SCIENCES INC·Filed 2016·Granted Apr 24, 2018·47 cites·15 claims
- 0697US11926645B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2021·Granted Mar 12, 2024·8 cites·65 claims
- 0797US11814406B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2023·Granted Nov 14, 2023·11 cites·22 claims
- 0897US9127006B2Modulators of toll-like receptorsGILEAD SCIENCES INC·Filed 2014·Granted Sep 8, 2015·44 cites·8 claims
- 0997US8367670B2Modulators of toll-like receptorsGILEAD SCIENCES INC·Filed 2009·Granted Feb 5, 2013·43 cites·19 claims
- 1094US12297226B2Compounds and methods for treatment of viral infectionsGILEAD SCIENCES INC·Filed 2024·Granted May 13, 2025·3 cites·28 claims
- 1194US8809330B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Aug 19, 2014·18 cites·10 claims
- 1294US8809527B2Modulators of toll-like receptorsGILEAD SCIENCES INC·Filed 2013·Granted Aug 19, 2014·16 cites·1 claims
- 1394US8629142B2Modulators of toll-like receptorsGILEAD SCIENCES INC·Filed 2012·Granted Jan 14, 2014·19 cites·19 claims
- 1494US8486938B2Pyrazolo[1,5-a]pyrimidines for antiviral treatmentBABAOGLU KERIM·Filed 2011·Granted Jul 16, 2013·25 cites·3 claims
- 1593US10172860B2Modulators of toll-like receptorsGILEAD SCIENCES INC·Filed 2017·Granted Jan 8, 2019·9 cites·9 claims
- 1693US8980878B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Mar 17, 2015·20 cites·31 claims
- 1793US7517988B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2007·Granted Apr 14, 2009·13 cites·15 claims
- 1893US7482466B2Hydroxamates as therapeutic agentsPHARMACYCLICS INC·Filed 2007·Granted Jan 27, 2009·13 cites·12 claims
- 1992US9238039B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2013·Granted Jan 19, 2016·13 cites·38 claims
- 2091US8946238B2Pyrazolo[1,5-A]pyrimidines as antiviral agentsGILEAD SCIENCES INC·Filed 2012·Granted Feb 3, 2015·15 cites·30 claims
- 2190US9452166B2Modulators of toll-like receptorsGILLEAD SCIENCES INC·Filed 2015·Granted Sep 27, 2016·11 cites·8 claims
- 2288US11110091B2Modulators of toll-like receptorsGILEAD SCIENCES INC·Filed 2018·Granted Sep 7, 2021·2 cites·3 claims
- 2383US9504689B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2015·Granted Nov 29, 2016·3 cites·20 claims
- 2483US8088770B2Modulators of pharmacokinetic properties of therapeuticsDESAI MANOJ C·Filed 2008·Granted Jan 3, 2012·6 cites·21 claims
- 2582US8987313B2Inhibitors of cytochrome P450DESAI MANOJ C·Filed 2011·Granted Mar 24, 2015·3 cites·20 claims
- 2681US8486942B2Modulators of pharmacokinetic properties of therapeuticsDESAI MANOJ C·Filed 2011·Granted Jul 16, 2013·3 cites·9 claims
- 2779US8759379B2Inhibitors of cytochrome P450DESAI MANOJ C·Filed 2008·Granted Jun 24, 2014·2 cites·24 claims
- 2875US12264173B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2023·Granted Apr 1, 2025·0 cites·20 claims
- 2974US2023295201A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3067US9957275B2Pyrazolo[1,5-A]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2017·Granted May 1, 2018·0 cites·17 claims
- 3166US2018298011A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2018·Application pending·0 cites
- 3265US2015139948A1Modulators of pharmacokinetic properties of therapeuticsDESAI MANOJ C·Filed 2014·Application pending·0 cites
- 3364US12110294B2CD73 compoundsGILEAD SCIENCES INC·Filed 2021·Granted Oct 8, 2024·0 cites·7 claims
- 3464US11767337B2Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Granted Sep 26, 2023·0 cites·43 claims
- 3563US2014017199A1Modulators of pharmacokinetic properties of therapeuticsGILEAD SCIENCES INC·Filed 2013·Application pending·0 cites
- 3662US2017158647A1Modulators of pharmacokinetic properties of therapeuticsGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3762US2017190708A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 3861US2022356196A1Antiviral compoundsGILEAD SCIENCES INC·Filed 2021·Application pending·0 cites
- 3959US2016130275A1Pyrazolo[1,5-a]pyrimidines for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4058US10174038B2Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2017·Granted Jan 8, 2019·0 cites·20 claims
- 4158US2016069915A1Modulators of pharmacokinetic properties of therapeuticsGILEAD SCIENCES INC·Filed 2015·Application pending·0 cites
- 4258US2017065592A1Modulators of toll-like receptorsGILLEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4357US2024124467A1Fused pyrimidine compounds as inhibitors of menin-mll interactionBIOMEA FUSION INC·Filed 2021·Application pending·0 cites
- 4455US2017029427A1Compounds and methods for antiviral treatmentGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4550US2016235748A1Pyrazolo[1,5-a]pyrimidines as antiviral agentsGILEAD SCIENCES INC·Filed 2016·Application pending·0 cites
- 4640US2013274254A1Inhibitors of cytochrome p450 (cyp3a4)CANNIZZARO CARINA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hon Chung Hui files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →